← Leaderboards
Jonathan David Charlesworth
Noctrix Health, Inc
$3,244,774
Attributed
$3,244,774
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,244,774 · 1
By mechanism
R44$3,244,774 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Life”
- Chanza Baytop · Westat, Inc.$271,217,917
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Beth Baseler · Leidos Biomedical Research, Inc.$105,136,677
- Paul F Gallagher · Woods Hole Oceanographic Institution$92,619,872
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- Martha Hering · Westat, Inc.$57,098,843
Research focus
LifeNerve FibersFda ApprovedLegal PatentMedicare ClaimMovementDoseEsthesiaDetectionLeadAdultDevicesMemoryBrainCenters For Disease Control And Prevention (U.S.)AffectEpidemicClinical TrialsAlgorithmsDesignFeedbackCommercializationControl TheoryNovel Therapeutics
Grant awards (4)
Developing closed-loop tonic motor activation therapy for treatment of refractory restless legs syndrome$515,503
R44 · FY2025 · NS · contact PI
Treatment of Restless Legs Syndrome through non-invasive peripheral nerve stimulation$1,064,334
R44 · FY2022 · NS · contact PI
Treatment of Restless Legs Syndrome through non-invasive peripheral nerve stimulation$1,203,447
R44 · FY2021 · NS · contact PI
Treatment of Restless Legs Syndrome through non-invasive peripheral nerve stimulation$461,490
R44 · FY2020 · NS · contact PI